You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NKTR Sale Disclosure
Zalevsky Jonathan · SEC Form 4 · Filed Aug 20, 2026
Sale
Calculated transaction value
$13.39K
Zalevsky Jonathan Chief R&d Officer
NKTR
Nektar Therapeutics
NKTR
Transaction date
Aug 18, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed 2 days later
NKTR daily price context
Close on/before transaction
$73.64
Aug 18, 2026
First close after public filing
$74.02
Aug 21, 2026
30-day return after filing
-9.7%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 186 shares @ $71.98
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-359588
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$13.39K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nektar Therapeutics NKTR Current | Sale | Aug 18, 2026 | $13.39K |